Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Crotty Alexander

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Research Square|June 6, 2022
The DNA glycosylase NEIL2 plays a vital role in combating SARS-CoV-2 infectionTapas Hazra, Nisha Tapryal, Anirban Chakraborty, et al.
The Journal of Allergy and Clinical Immunology|February 18, 2026
PrecISE- A Biomarker Stratified Adaptive Trial of 5 Interventions in Severe Asthma: Final Protocol and the Baseline CohortLoren C Denlinger, Elliot Israel, Wendy C Moore, et al.
The Journal of Allergy and Clinical Immunology|March 5, 2021
PrecISE: Precision Medicine in Severe Asthma: An adaptive platform trial with biomarker ascertainmentElliot Israel, Loren C Denlinger, Leonard B Bacharier, et al.
The Journal of Allergy and Clinical Immunology|December 1, 2021
The Precision Interventions for Severe and/or Exacerbation-Prone (PrecISE) Asthma Network: An overview of Network organization, procedures, and interventionsSteve N Georas, Rosalind J Wright, Anastasia Ivanova, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Research Square|June 6, 2022
The DNA glycosylase NEIL2 plays a vital role in combating SARS-CoV-2 infectionTapas Hazra, Nisha Tapryal, Anirban Chakraborty, et al.
The Journal of Allergy and Clinical Immunology|February 18, 2026
PrecISE- A Biomarker Stratified Adaptive Trial of 5 Interventions in Severe Asthma: Final Protocol and the Baseline CohortLoren C Denlinger, Elliot Israel, Wendy C Moore, et al.
The Journal of Allergy and Clinical Immunology|March 5, 2021
PrecISE: Precision Medicine in Severe Asthma: An adaptive platform trial with biomarker ascertainmentElliot Israel, Loren C Denlinger, Leonard B Bacharier, et al.
The Journal of Allergy and Clinical Immunology|December 1, 2021
The Precision Interventions for Severe and/or Exacerbation-Prone (PrecISE) Asthma Network: An overview of Network organization, procedures, and interventionsSteve N Georas, Rosalind J Wright, Anastasia Ivanova, et al.
Pageof 2